The Filing Desk

111

YI · Nasdaq · Health Care · Financials, fiscal 2016 to 2025

YI · Last close · November 19, 2026
$2.51

111's revenue fell 12.8% to CN¥12.6 billion in fiscal 2025. Its operating margin was −0.0%, about the same as 0.0% a year earlier. Free cash flow was CN¥115 million, down 53.7%. The diluted share count rose 1.3%.

111, Inc. Latest fiscal year ended December 31, 2025 20-F filed April 30, 2026 · 0001104659-26-052002 Updated
Revenue
CN¥12.6B
12.8%
Operating margin
−0.0%
0.0 pts
Net income
−CN¥22M
 
Free cash flow
CN¥115M
53.7%
Return on equity
—
 

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity.

About these figures. 111 is a foreign company: it files an annual report on Form 20-F, prepared under US accounting standards (US GAAP), instead of a 10-K, and no quarterly reports, so this page has fiscal years only. Its shares trade in the US as American depositary shares (ADSs), and one ADS can stand for several ordinary shares, so per-share figures are per ordinary share and the page has no market value, P/E or valuation model. Its figures are in CNY, as it reports them: they aren't converted to US dollars.

Income statement

Revenue and net income
CNY billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
CNY billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

111 lost money in fiscal 2025: a net loss of CN¥22 million.

Diluted earnings per share
CNY per ordinary share, fiscal years; loss years in red. One US-listed ADS can stand for several ordinary shares.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
CNY billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
CNY billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments844880654—561
Debt incl. finance leases—————
Net debt (negative means net cash)—————
Net debt to EBITDA—————
Debt to equity—————
Interest coverage−117.0x−27.6x−17.4x0.1x−0.1x
Current ratio1.3x1.2x1.1x1.1x1.1x
Quick ratio0.8x0.6x0.6x0.5x0.6x
CNY millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
CNY billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
CNY billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
CNY billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score———
Rule of 407.5%−1.9%−11.9%
Altman Z''−4.61−4.10−5.73
Accruals ratio2.9%−9.7%−5.7%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positiveFailFailFail
Cash from operations is positiveFailPassPass
Return on assets rosePassPassFail
Cash from operations exceeds net incomeFailPassPass
Debt fell relative to assets———
Current ratio roseFailPassFail
Share count didn't riseFailFailFail
Gross margin roseFailPassPass
Revenue rose relative to assetsPassPassFail
F-score———
Companies that report no gross profit are scored on the other eight.

Compare

Put 111 side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
111FY25−12.8%−0.0%0.9%———
Henry ScheinFY254.0%5.0%4.3%7.5%3.1x6Compare
MedlineFY2511.5%7.8%4.6%—3.3x—Compare
Accendra HealthFY253.1%1.0%−10.6%1.2%7.3x2Compare
Cardinal HealthFY2614.2%1.0%1.8%—1.1x6Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

10 years of figures

Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue8749601,7863,9528,20312,42613,51714,94814,40112,556
Revenue growth—9.8%86.1%121.3%107.6%51.5%8.8%10.6%−3.7%−12.8%
Gross profit7480104165366621840849829723
Research and development——————————
Operating income−364−254−400−494−473−642−371−3502−2
Net income−363−249−382−502−467−621−376−353−21−22
Diluted EPS (CNY)−5.81−3.45−3.82−3.05−2.77−4.04−2.50−2.33−0.38−0.38
Diluted shares (millions)7272100164165166167169172174
Cash flow
Cash from operations−389−204−343−512−117−689−23−447263119
Capital expenditure57142026633210154
Free cash flow−394−211−357−532−142−751−55−457248115
Dividends paid0000000000
Share buybacks000231260000
Acquisitions0000000000
Stock-based compensation3105154761461622272010
Balance sheet at fiscal year end
Cash and short-term investments3744611,106—1,490844880654—561
Debt incl. finance leases——————————
Total assets—7631,5461,6103,0263,1463,4743,0892,7882,200
Total liabilities—2013238361,6962,2972,8262,8132,4071,986
Shareholders' equity−688−9461,224777357−173−415−584−643−702
Margins and ratios
Gross margin8.5%8.4%5.8%4.2%4.5%5.0%6.2%5.7%5.8%5.8%
Operating margin−41.7%−26.5%−22.4%−12.5%−5.8%−5.2%−2.7%−2.3%0.0%−0.0%
Net margin−41.6%−26.0%−21.4%−12.7%−5.7%−5.0%−2.8%−2.4%−0.1%−0.2%
Free cash flow margin−45.1%−22.0%−20.0%−13.5%−1.7%−6.0%−0.4%−3.1%1.7%0.9%
Rule of 40 (growth + FCF margin)—−12.2%66.1%107.8%105.8%45.4%8.4%7.5%−1.9%−11.9%
Return on capital——————————
Return on equity——−274.7%−50.2%−82.4%—————
Return on assets——−33.1%−31.8%−20.1%−20.1%−11.4%−10.8%−0.7%−0.9%
Net debt to EBITDA——————————
CNY millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, CNY millions)
Source: 111's Form 20-F filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with 111.